Respiratory Flashcards

(81 cards)

1
Q

Outline the MRC dyspnoea scale

A

1) Not troubled by SoB (except on strenous exercise)

2) SoB when hurrying or going up slight hill

3) Walks slower than contempories on flat/has to stop for breath

4) Stops for breath approx 100m or after a few minutes

5) Too SoB to leave house or SoB on dressing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Respiratory Causes of Clubbing

A

ABCDEF

A - Asbestosis & Abscess

B - Bronchiectasis & tB

C - CF

D - “Dirty” tumours e.g. mesothelioma

E - Empyema

F - Fibrosing Alveolitis (IPF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Features of Life-Threatening Asthma

A

PEFR<33%
Silent chest
Poor respiratory effort
Bradycardia, hypotension
Arrhythmia
Exhaustion
Confusion/Coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is COPD?

A

Chronic obstructive airways disease
Limited reversibility
Combination of bronchitis and emphysema

Abnormal inflammatory response in airways leads to mucus hypersecretion and chronic tissue destruction –> remodelling –> fibrosis –> increased airway resistance

Commonest cause = cigarette smoking
Also consider alpha 1 antitrypsin deficiency and occupation (e.g. coal mining)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Clinical Features of COPD

A

Look around bedside for inhalers
?LTOT
Cachexic? Cushingoid appearance?

Pursed lip breathing
Use of accessory muscles
Bounding pulse
CO retention flap (asterixis)

Hyperinflated chest
Hyperresonance to percussion
Expiratory wheeze
?coarse crepitations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Can you name any severity indexes used for COPD?

A

MRC dyspnoea scale

Gold Staging for Airflow obstruction
- FEV1/FVC < 0.7, FEV1 <80%

BODE index
- FEV1
- 6 minute walk distance
- BMI
- MRC dyspnoea scale

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How would you investigate someone in whom you suspect they have COPD?

A

Spirometry with reversibility testing
- FEV1/FVC < 0.7
- FEV1 < 0.8
- Minimal reversibility with bronchodilators
ECG

Bloods
- Routine including FBC (?polycythaemia), inflammatory markers, U&Es, LFTs (albumin may be low in chronic disease)
- ABG if ongoing oxygen requirement
- alpha1AT levels if young/FHx/minimal smoking history

CXR
- ?hyperinflation ?bullae ?flattened hemidiaphragm

HRCT
- Useful to grade and classify emphysema

Echocardiogram
- ?pulm HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe some key differences between COPD and Asthma

A

1) COPD more likely in smokers/ex-smokers

2) Asthma = diurnal pattern
- Serial peak flow measurements will show >20% diurnal variation

3) Asthma = history of triggers, history of atopy

4) Asthma = evidence of reversibility on spirometry with bronchodilators (>400mL improvement)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are common causes of COPD exacerbations?

A

Infection (60%)
- Viruses e.g. influenza, parainfluenza, rhinovirus
- Bacteria e.g. haemophilus influenzae, streptococcus pneumoniae, pseudomonas

Environmental pollution

Unknown (30%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Outline the management of COPD

A

O PARISIAN

Oxygen therapy
- To slow rate of progression to cor pulmonale

Pulmonary Rehab
= MDT programme of physio, nutrition team, education and behavioural intervention
- Indicated if MRC<3

Azithromycin
- Anti-inflammatory rather than long term antibiotic
- Reduce rate of exacerbations
- Indicated if >3 exacs requiring steroids or 1 exac requiring hospitalisation / year

Reduction of Lung volume (surgery)

Inhalers
- SABA/LABA +/- ICS +/- LAMA

Smoking Cessation
- Only treatment shown to alter disease progression

Immunisations
- Annual influenzae
- Pneumococcal if <65 or FEV1<40%

Anti-mucolytics e.g. Acetylcisteine
- Reduce risk of chest infections

Nutrition
- Poor nutritional state is linked to increased mortality and reduced immune function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

When is Long Term Oxygen Therapy indicated in patients with COPD?

A

PaO2 < 7.3
or
PaO2 <8.0 if polycythaemic/nocturnal hypoxia/cor pulmonale or pulm HTN

Typically use >15 hours/day
Can also consider ambulatory or short burst O2 therapy

Home assessment before prescription
No smoking!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Indications for Lung Transplant in patients with COPD

A

BODE index >5
Post bronchodilator FEV1 <25%
Resting hypoxia and hypercapnia
Pulmonary HTN
Accelerated decline in FEV1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Can you outline medications we can offer to help with smoking cessation?

A

1) Nicotine Replacement Therapy
- Assess no. cigarettes/day to help with dosing
- When is their first cigarette? If on waking consider 24 hour patch as opposed to 16 hour
- Patches (long acting) +/- gum +/- inhalator
- Combination of long acting and short acting best

2) Buproprion
- Antidepressant and nicotinic antagonist
- Contraindicated in breastfeeding/pregnancy
- Risk of seizures

3) Varenicline
- Nicotine receptor agonist
- 12 week course
- Nausea/insomnia/abnormal dreams/neuropsychological effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Indications for NIV

A

COPD Resp acidosis after 1 hour maximal therapy
= pH <7.35, pCO2 >6

Severe dyspnoea with resp muscle fatigue

T2RF secondary to chest wall deformity/neuromuscular disease/OSA

Cardiogenic pulmonary oedema unresponsive to CPAP

Weaning from tracheal intubation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Benefits of NIV

A

Bi-level positive airway pressure
- IPAP aids ventilation = removal of CO2
- EPAP recruits collapsed alveoli = improves gas exchange = improves oxygenation

Reduces needs for invasive intubation
(reduce risk of ventilator complications)
Reduce mortality
Reduce length of stay in hospital

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Contraindications for NIV

A

Severe hypoxia (?consider if intubation and ventilation more appropriate)

Undrained pneumothorax

Facial injury

Burns

Fixed upper airway obstruction

Excessive secretions/vomiting

Reduced GCS/agitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Indications for CPAP

A

Continuous positive airway pressure (PEEP, basically EPAP)

T1RF
Cardiogenic pulmonary oedema
Congestive cardiac failure
Pneumonia
Sleep apnoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Outline common causes of Community Acquired Pneumonia

A

Strep pneumoniae (most common)
Haemophilus influenzae
Mycoplasma pneumoniae
Legionella
Staph Aureus (post influenza)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is CURB scoring?

A

C - confusion
U - Urea>7
R - RR > 30
B - BP systolic <90
>65

<2 points, consider treating in community

CURB score of 5 has 57% 30 day mortality
CURB score of 3 has 17% 30 day mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is Bronchiectasis?

A

Abnormal permanent dilatation and destruction of bronchi due to combination of
1) Chronic infection
2) Impaired mucus drainage
3) Airway obstruction
4) Defective host response

Occurs in distal bronchioles (no cartilage rings)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Causes of Bronchiectasis

A

CONGENITAL
- Cystic fibrosis (autosomal recessive)
- Kartagener’s (autosomal recessive)
- Young’s syndrome
- Yellow Nail syndrome

COPD

INFECTION
- Childhood infections e.g. measles, pertussis, TB
- Recurrent aspiration

OVERACTIVE IMMUNITY
- ABPA

UNDERACTIVE IMMUNITY
- HIV
- Leukaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Outline some complications of Bronchiectasis

A

Recurrent infections e.g. pseudomonas aeruginosa, haem influenzae

Empyema/abscess

Haemoptysis (can be MASSIVE!)

Cor Pulmonale

Cachexia

Anaemia of chronic disease

Metastatic infection e.g. CNS abscess

Secondary amyloidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Investigation Screen for Bronchiectasis

A

Sputum MC&S and AFB (multiple samples)
Spirometry - usually obstructive picture

Bloods
- Routine = FBC, U&Es, LFTs, inflam markers
- HIV
- Immunoglobulins
- Interferon gamma release assay if suspicious of TB
- Autoantibodies (vasculitis screen)
- Alpha 1 AT levels
- Aspergillus precipitans & IgE levels

CXR

HRCT is definitive test
- “Reid Classification” e.g. signet ring, tree-in-bud, tram-tracking

?Bronchoscopy

EXTRAS
- Sweat testing/genotyping if ?CF
- Nasal brushings if ?Kartagener’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Outline the management of Bronchiectasis

A

Treat underlying pathology

CONSERVATIVE
- Stop smoking
- Optimise nutrition
- Vaccinations
- Sputum clearance/chest physio

MEDICAL Rx
- Antibiotics for infective exacerbations (10-14 days)
- Prophylactic azithromycin (antiinflam)
- Inhaled bronchodilators
- Inhaled steroids
- Mucolytics

SURGICAL Rx
- ?Lobectomy if localised
- Lung transplant in CF patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Cystic Fibrosis
Autosomal recessive disease Defect in CFTR gene on chromosome 7 - Most common defect = deltaF508 - Carrier rate = 1 in25 Defect in CFTR = chloride ions cannot leave cells = sodium and water reabsorption from mucus back into cells = thick viscous secretions Multisystem disorder - Nasal polyps - Bronchiectasis and recurrent chest infections - Diabetes (30% by age of 50) - Malabsorption/FTT - Biliary cirrhosis --> CLD (30%) - Delayed puberty - Infertility Most diagnosed in neonatal period but 5% diagnosed after age of 18
26
Examples of common colonising organisms in CF
Haemophilus influenzae (early childhood) Staph Aureus Pseudomonas Aspergillus Burkholderia Cepacia = worst prognosis! - Contraindication to lung transplant
27
Outline the management of CF
MDT Approach CONSERVATIVE - Daily chest physio and postural drainage - Optimise nutrition - Minimise contact with other CF pts (avoid cross infection) - Vitamin supplements - Pancreatic supplements PHARMACOLOGICAL - Treatment of pseudomonas colonisations with PO and nebulised antibiotics - Lumacaftor / Ivacaftor = indicated if homozygous delta F508 mutation. Increases number of CFTR proteins SURGICAL - Heart and lung transplant (5yr survival 60%) Median survival 32 years but is improving
28
What is Young's Syndrome?
Rare condition, unknown cause Triad of 1) Azoospermia 2) Bronchiectasis 3) Rhinosinusitis Often present in middle age with infertility
29
What is Yellow Nail Syndrome?
Rare condition, unknown cause Usually affects >50s 2 of the 3: 1) Slow growing hard yellow finger and toe nails 2) Lymphoedema 3) Recurrent Pleural effusions + bronchiectasis
30
What is TB?
Infection caused by mycobacterium tuberculosis Notifiable disease
31
Risk Factors for Active Pulmonary TB infection
Place of birth (Sub Sahara Africa & Asia) Increasing age HIV/AIDs Homelessness/Overcrowded living spaces e.g prisons Immunosuppression e.g. diabetes, chemo Malignancy Malnutrition
32
Outline some examples of extra pulmonary TB
TB meningitis CNS tuberculoma Scrofuloderma (cervical LNs) Pericardial TB Pott's disease = spinal osteomyelitis Spinal TB Renal TB Miliary TB = haematogenous spread to any organ
33
How would you investigate a patient in whom you suspect TB?
Sputum samples x 3 for Ziehl Neelsen staining Early morning urine samples for AFB x 3 Tuberculin skin resting (Mantoux) - Can be false negative if immunosuppressed Interferon gamma Release Assay (Quantiferon) HIV CXR CT Chest ?Bronchoscopy ?Biopsy of extrapulmonary site e.g. LNs
34
Outline the management of TB
Notifiable disease! Inform public health - contract tracing May need to have directly observed treatment if no fixed abode/non-compliant RIPE medications - Prior to starting, check LFTs and visual acuity/colour - Typical course is 6 months of R & I, 2 months of P &E RIFAMPICIN - Enzyme inducer, red urine, GI disturbance ISONIAZID - Hepatitis, peripheral neuropathy PYRAZINAMIDE - Hepatoxicity, peripheral neuropathy, gout ETHAMBUTOL - Optic neuritis
35
Potential Clinical Features of a patient with TB previously treated with surgical intervention e.g. plombage, phrenic nerve crush
Tracheal deviation towards side of previous TB Phrenic nerve crush scar in supraclavicular fossa Chest deformity/asymmetry Thoracotomy/thoracoplasty (rib resection) scar Reduced chest expansion on TB side Dullness to percussion
36
Possible respiratory complications of TB
Apical fibrosis Aspergilloma in old TB cavity Bronchiectasis secondary to LN obstruction Pleural effusion/thickening
37
Causes of Upper Zone Pulmonary Fibrosis
CHARTS Coal Worker's pneumoconioses Histoplasmosis Hypersensitivity pneumonitis Histiocytosis X Ankylosing spondylitis ABPA Radiation TB Sarcoidosis Silicosis
38
Causes of Lower Zone pulmonary fibrosis
RADIO Rheumatoid arthritis Asbestosis Drugs e.g. amiodarone, nitrofurantoin Idiopathic PF (IPF) Other e.g. bronchiectasis, CTD e.g. SLE or systemic sclerosis, sjogren's
39
Iatrogenic/Drug causes of Pulmonary Fibrosis
"BBC is everyMANS Gold" Bleomycin Busulphan Cyclophosphamide Methotrexate Amiodarone Nitrofurantoin Sulphasalazine Gold
40
Investigations for Pulmonary Fibrosis
LAB - Routine bloods; ?eosinophilia on FBC (EAA) - Immunoglobulins (ABPA) - ACE (sarcoidosis) - CK (myositis) - Rheumatological screen e.g. ANA, RF, anti-DSNA, anti-Scl70, anti centromere FUNCTIONAL - Pulmonary function tests + DLCO (Restrictive pattern with low DLCO) - 6 minute walking test RADIOLOGICAL - CXR - HRCT is key test (Assess pattern, extent and distribution of fibrosis) INVASIVE - Bronchoscopy with Bronchoalveolar Lavage - ?Lung biopsy
41
Management of Pulmonary Fibrosis
Depends on underlying cause CONSERVATIVE - Pulmonary rehab PHARMACOLOGICAL - Corticosteroids - less likely to respond if male/late presentation/honeycombing on CT/BAL neutrophilia - Immunosuppression e.g. AZA/MTX - Supplemental Oxygen - Antifibrotics e.g. pirfenidone (Specialist MDT decision, FVC 50-80%) - Symptom Management e.g. benzos, opiates SURGICAL - Lung transplant may be suitable in some cases
42
What are the indications for lung transplant in UIP?
<65 years old TLCO<40% predicted Fall in FVC > 10% over 6 months
43
Rheumatoid Lung Disease
1) Pleural effusions/pleurisy 2) Pulmonary nodules - Can precede arthritis 3) Fibrotic Lung disease - Lower zone 4) Caplan Syndrome = coal worker's pneumoconioses & RA 5) Obliterative Bronchiolitis - Small airways obstructions --> necrotising bronchiolitis - Linked to Gold & penicillamine
44
5 main types of pleural effusions
1) Transudates - Raised hydrostatic or low oncotic pressures 2) Exudates - Increased capillary permeability 3) Chylothorax - Disruption of lymphatic ducts 4) Empyema - Infection of pleural space 5) Haemothorax - Bleeding into pleural space
45
Transudative Pleural Effusions
Pleural protein < 20g/L CHAM C- CCF H - Hypoalbuminaemia / Hypothyroidism A - All failures (liver, renal) M - Meig's syndrome (= benign ovarian fibroma & right sided effusion)
46
Exudative Pleural Effusions
Pleural protein >30g/L PINTS P -Pneumonia I - Infarction (PE) N - Neoplasia e.g. mesothelioma, metastases T - TB/Trauma S - Sarcoidosis/Scleroderma
47
What is Light's Criteria?
Used if pleural protein level equivocal e.g. 25g/L Pleural effusion is an EXUDATE if ... 1) Pleural Albumin/Serum Albumin > 0.5 2) Pleural LDH/Serum LDH > 0.6 3) Pleural LDH > 2/3 of ULN of serum LDH HOWEVER - 25% of transudates mistakenly identified as exudates using light's criteria
48
Investigations for Pleural Effusions
Sputum MC&S +/- AFB Bloods - Routine - ?Blood cultures - Serum albumin and LDH CXR - >300mL to be seen on PA film - >1000mL if mediastinal shift seen USS ?CT thorax ?Bronchoscopy ?CT guided biopsy ?VATS PLEURAL ASPIRATE TESTS Pleural Fluid - Cell Count - Cytology - Albumin & LDH (Light's) - Glucose - pH (<7.2 = empyema!) - Amylase (if suspicious of pancreatitis/oesophageal rupture) - Lipids (if suspicious chylothorax)
49
What might a pleural fluid glucose <2.0 indicate?
Malignancy Empyema Arthritis (RA) TB
50
What is the safety triangle for chest drain insertion?
Base of axilla Lateral edge of pectoralis major Lateral edge of latissimus dorsi 5th Intercostal Space
51
Management of Acute Tension Pneumothorax
Emergency! A to E 14 - 16 gauge cannula into 2nd or 3rd intercostal space, midclavicular line Chest drain (safety triangle)
52
How would you manage a primary pneumothorax?
Primary pneumothorax = no history of underlying lung disease. Usually young, tall, thin men A to E assessment If <2cm and asymptomatic = supportive e.g. pain relief and oxygen therapy If >2cm or symptomatic = aspirate with cannula in 2nd-3rd ICS - If unsuccessful, chest drain
53
How would you manage a secondary pneumothorax?
Secondary pneumothorax = due to underlying respiratory disease e.g. Asthma, COPD If <50 & <2cm & asymptomatic = Supportive +/- aspirate If > 50 & > 2cm +/- symptoms = chest drain
54
Can you outline some advice we give to patients once they've had a pneumothorax?
Avoid smoking (increases risk of pneumoT) No flying in 7 days after treatment Avoid scuba diving for rest of life (unless undergo bilateral surgical pleurectomy)
55
Indications for Surgical Intervention for Pneumothorax
Persistent air leak Repeat pneumothorax - 1st contralateral - 2nd ipsilateral Bilateral spontaneous pneumothoraces
56
What is Obesity Hypoventilation Syndrome?
3 of 1) OSA 2) Hypercapnia 3) Restrictive PFTs
57
Investigating OSA
Epworth Sleepiness Scale Overnight Polysomnography - Measures ECG, EMG, resp effort and oxygenation overnight - Number of apnoeas overnight FBC (polycythaemia) TFTs (?hypothyroidism) Morning ABG
58
Management of OSA
CONSERVATIVE - Advise weight loss if overweight (only 50% of OSA pts are obese) - Stop smoking - Reduce alcohol intake MEDICAL - CPAP = 1st line Rx but issues with compliance - LTOT Surgical intervention rare
59
Complications of OSA
HTN IHD & MIs Arrhythmias Stroke Pulmonary HTN OHS
60
Outline the types of lung cancer
NON SMALL CELL LUNG CANCER - Most common, 75-80% - 3 main subtypes = SCC > adenocarcinoa > large cell SMALL CELL LUNG CANCER - 20-25% of lung cancers - Arise from APUD cells - Rapidly growing with early metastases
61
Common sites of lung cancer metastases
Brain Liver Adrenal Glands Bone - osteolytic appearance, often in vertebral bodies
62
Investigating for Lung Cancer
Lung Function Tests - Suitability for surgical intervention Sputum Cytology - Positive in 20% Bloods - Routine (Na+ for SIADH, LFTs) Imaging CXR can be useful in first instance CT CAP - Evaluate tumour location & size, LNs & ?mets - Identify site for biopsy PET-CT scan - More accurate at identifying mediastinal disease (?site for EBUS) TISSUE SAMPLING EBUS - nodal disease CT guided biopsy - of mets or peripherally located cancer Flexible bronchoscopy Mediastinoscopy VATS & pleural biopsy
63
Paraneoplastic Features of NSCLC
Parathyroid-hormone Related Protein Secretions - Raised PTHrP = hypercalcaemia - SCC Hypertrophic Pulmonary Osteoarthropathy - Clubbing and pain at wrist and ankles due to new bone formation - Adenocarcinoma & SCC BCG Secreting Tumour - Gynaecomastia - Adenocarcinoma & large cell
64
Management of NSCLC
Lung Cancer MDT Consider if suitable for surgical resection - Stage I or II TNM - FEV1 >2L (if pneumonectomy); FEV1 > 1.5L (if lobectomy) Radiotherapy - Stage I - III if inoperable Chemotherapy - Post op or on its own - Stage III-IV Palliative Chemo/Radiotherapy if stage IV Advanced Care Planning Symptom control
65
Contraindications for Surgical Intervention for NSCLC
Stage IIIb/IV (mets present) FEV1<1.5L Malignant pleural effusion Tumour near hilum Vocal cord paralysis SVCO Left recurrent laryngeal nerve palsy
66
Paraneoplastic Features of SCLC
Ectopic ADH secretion - = SIADH, with low sodium Ectopic ACTH Secretion - Cushing's syndrome = HTN, raised glucose, hypokalaemia, muscle weakness Lambert-Eaton Myasthenic Syndrome (LEMS) - Antibodies against VGCC - Can precede diagnosis of lung cancer
67
How is SCLC staged and mangaged?
Staged as either: 1) Limited = disease confined to ipsilateral hemithorax = 15-20 months median survival 2) Extensive = metastatic disease outside ipsilateral hemithorax = 8-13 months median survival MDT Approach Unlikely to be suitable for surgical intervention Combination of radiotherapy and chemotherapy
68
What is Pancoast's Tumour?
Tumour in lung apex Most commonly NSCLC (and usually SCC) Invasive! - chest wall/ribs/brachial plexus/cervical sym nerves PANCOAST'S SYNDROME = Shoulder and arm pain along C8-T1 dermatomes Horner's Syndrome = miosis, ptosis, enophthalmos & anihydrosis Hand muscle weakness & wasting
69
What is SVCO?
Superior Vena Cava Obstruction Oncological emergency! Most common in lung cancer (SCLC>NSCLC) and lymphoma FEATURES - Cough, SoB - Headache, worse on bending forwards - Syncope - Hoarse voice - Facial & upper limb oedema - Facial plethora - Superficial vein distension of upper body - Fixed elevated JVP - Inspiratory stridor - Pemberton's sign = facial swelling on lifting of both arms
70
How would you manage a patient with SVCO?
A to E assessment Inform anaesthetic team and oncology team Corticosteroids mainstay of treatment - If evidence of respiratory compromise = IV dexamethasone ?Endovascular stenting ?Chemo/Radiotherapy (if unable to lie flat, unlikely to be able to tolerate radiotherapy)
71
Indications for Pneumonectomy/Lobectomy
Resection of lung malignancy - NSCLC mainly (25% suitable) Localised bronchiectasis with uncontrolled symptoms Old TB (prior to pharmacological Rx) Fungal infections e.g. aspergilloma Traumatic lung injury Large emphysematous bullae CF
72
What FEV1 values do you need for a pneumonectomy?
FEV1 > 2L
73
What FEV1 values do you need for a lobectomy?
FEV1 > 1.5L
74
Indications for VATS
Lobectomy & pneumonectomy (less invasive) Pleural biopsy Lung parenchymal biopsy Bullectomy & lung volume reduction for emphysema Correction of spontaneous primary pnemothorax Pleurodesis Wedge resection
75
Benefits of VATs as opposed to "traditional" thoracic surgery
Minimally invasive - Reduce need for muscle division & rib spreading/fractures Quicker recovery Reduced length of stay in hospital Earlier mobilisation Lower doses opiates/analgesics required All adds up to reduce risks associated with hospital admissions e.g. HAI, delirium
76
Indications for Lung Transplant
ILD Advanced COPD (usually single) CF Emphysema secondary to alpha1AT Pulmonary HTN Single = if >65 years old Double = <60 years old CRITERIA - >50% chance of death within 2 years if no transplant - >80% chance of survival >90 days - >80% chance of 5yr survival
77
Contraindications for Lung Transplant
Severe organ dysfunction e.g. cardiac failure Acute Critical Illness Severe malnutrition/obesity Smoking in last 6 months Malignancy in last 5 years Poor exercise tolerance/unable to walk
78
What is a Bullectomy?
= removal of giant bullae Can help improve symptoms and lung function (restores mechanical linkage between chest wall and lungs) Indications 1) Progressive SoB despite maximal Rx AND 2) FEV1<50% AND 3) Bullae>1/3 of hemithorax
79
What is Cor Pulmonale?
= enlargement and failure of right side of heart due to increased vascular resistance secondary to respiratory disorder e.g. COPD Fluid retention & pulmonary HTN --> increased strain on RV --> RV failure Best treatment = prevention! Will likely need LTOT & diuretics
80
Signs of Bronchiectasis
Oxygen therapy Sputum pots Inhalers Likely young if CF Wet cough, ?cachexia Clubbing, ?yellow nails Midline/central line/portacath (?long term abx therapy) ?lymphadenopathy Non deviated trachea Coarse crackles ?Scars from previous lobectomy/wedge resection
81
COPD Spirometry Diagnostic Values
FEV1/FVC < 0.7 Severity: FEV1 0.8 - 1.0 = mild FEV1 0.5 - 0.8 = moderate FEV1 0.3 - 0.5 = severe FEV1 <0.3 = very severe